KT-5720 REVERSES MULTIDRUG-RESISTANCE IN VARIANT S49 MOUSE LYMPHOMA-CELLS TRANSDUCED WITH THE HUMAN MDR1 CDNA AND IN HUMAN MULTIDRUG-RESISTANT CARCINOMA-CELLS

被引:12
作者
GALSKI, H
LAZAROVICI, P
GOTTESMAN, MM
MURAKATA, C
MATSUDA, Y
HOCHMAN, J
机构
[1] HEBREW UNIV JERUSALEM, INST LIFE SCI, DEPT CELL & ANIM BIOL, IL-91904 JERUSALEM, ISRAEL
[2] HADASSAH UNIV HOSP, MOLEC BIOL & GENET ENGN UNIT, IL-91240 JERUSALEM, ISRAEL
[3] HEBREW UNIV JERUSALEM, SCH PHARM, DEPT PHARMACOL & EXPTL THERAPEUT, IL-91120 JERUSALEM, ISRAEL
[4] NCI, CELL BIOL LAB, BETHESDA, MD 20892 USA
[5] KYOWA HAKKO KOGYO CO LTD, TOKYO 194, JAPAN
关键词
CHEMOSENSITIZERS; K-252A DERIVATIVES; KT-5720; MDR1; MULTIDRUG RESISTANCE; P-GLYCOPROTEIN; PROTEIN KINASES; PROTEIN KINASE INHIBITORS;
D O I
10.1016/0959-8049(94)00511-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
T-25-Adh cells, cell variants derived from S49 mouse lymphoma, were transduced with a retrovirus containing the human MDR1 cDNA. The resultant cells (HU-1) are cross-resistant to colchicine, doxorubicin, vinblastine and actinomycin D, and their resistance to colchicine is reversed by verapamil. HU-1 cells were used to screen several protein kinase modulators for their ability to reverse multidrug resistance. Among the tested indole carbazole (K-252a) family of protein kinase inhibitors, only the antibiotic alkaloid KT-5720 (9-n-hexyl derivative of K-252a) could overcome the multidrug resistance of HU-1 cells and KB-V1 human carcinoma cells. Since other protein kinase A, C and G modulators did not reverse multidrug resistance in the tested multidrug-resistant cells, the chemosensitising activity of KT-5720 on these cells is apparently independent of its kinase inhibitory effects. Since KT-5720 fully reversed multidrug resistance at non-toxic concentrations, it might be a candidate for clinical chemosensitisation in combination chemotherapy.
引用
收藏
页码:380 / 388
页数:9
相关论文
共 32 条
[1]   THE CELL BIOLOGY OF MULTIPLE-DRUG RESISTANCE [J].
BECK, WT .
BIOCHEMICAL PHARMACOLOGY, 1987, 36 (18) :2879-2887
[2]  
BIEDLER JL, 1970, CANCER RES, V30, P1174
[3]  
CENTER MS, 1985, BIOCHEM PHARMACOL, V34, P1471, DOI 10.1016/0006-2952(85)90686-0
[4]  
CHAMBERS TC, 1992, MOL PHARMACOL, V41, P1008
[5]   AN ALTERED PATTERN OF CROSS-RESISTANCE IN MULTIDRUG-RESISTANT HUMAN-CELLS RESULTS FROM SPONTANEOUS MUTATIONS IN THE MDR1 (P-GLYCOPROTEIN) GENE [J].
CHOI, K ;
CHEN, C ;
KRIEGLER, M ;
RONINSON, IB .
CELL, 1988, 53 (04) :519-529
[6]   THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCE [J].
ENDICOTT, JA ;
LING, V .
ANNUAL REVIEW OF BIOCHEMISTRY, 1989, 58 :137-171
[7]  
FOJO A, 1985, CANCER RES, V45, P3002
[8]  
FORD JM, 1990, PHARMACOL REV, V42, P155
[9]   EXPRESSION OF A HUMAN MULTIDRUG RESISTANCE CDNA (MDR1) IN THE BONE-MARROW OF TRANSGENIC MICE - RESISTANCE TO DAUNOMYCIN-INDUCED LEUKOPENIA [J].
GALSKI, H ;
SULLIVAN, M ;
WILLINGHAM, MC ;
CHIN, KV ;
GOTTESMAN, MM ;
PASTAN, I ;
MERLINO, GT .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (10) :4357-4363